• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 POS filed by ECMOHO Limited

    12/9/22 4:01:24 PM ET
    $MOHO
    Catalog/Specialty Distribution
    Consumer Discretionary
    Get the next $MOHO alert in real time by email
    S-8 POS 1 tm2232168d1_s8pos.htm S-8 POS

     

    As filed with the Securities and Exchange Commission on December 9, 2022

    Registration No. 333-236027

    Registration No. 333-257546

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    post-effective Amendment No. 1

    To

    FORM S-8

     

    REGISTRATION STATEMENT NO. 333-236027

     

    REGISTRATION STATEMENT NO. 333-257546

     

    REGISTRATION STATEMENT

    UNDER

    THE SECURITIES ACT OF 1933

     

     

     

    ECMOHO Limited

    (Exact name of registrant as specified in its charter)

     

     

     

    Not Applicable

    (Translation of registrant’s name into English)

     

     

     

    Cayman Islands   Not Applicable
    (State or other jurisdiction of   (I.R.S. Employer
    incorporation or organization)   Identification Number)

     

    5th Floor, 909 Tianyaoqiao Road Xuhui District

    Shanghai, 200030

    The People’s Republic of China

    +86-21-5456-5223

    (Address and telephone number of registrant’s principal executive offices)

     

     

     

    2018 Omnibus Incentive Plan

    2021 Omnibus Incentive Plan

    (Full title of the plan)

     

     

     

    Cogency Global Inc.

    122 East 42nd Street, 18th Floor

    New York, NY 10168

    (800) 221-0102

    (Name, address and telephone number of agent for service)

     

     

     

    Copies to:

     

    Leo Zeng

    Chief Financial Officer ECMOHO Limited

    5thFloor, 909 Tianyaoqiao Road Xuhui
    District

    Shanghai, 200030

    The People’s Republic of China

    +86-21-5456-5223

     

    Dan Ouyang, Esq.

    Wilson Sonsini Goodrich & Rosati

    Professional Corporation

    Unit 2901, 29F, Tower C, Beijing Yintai Centre

    No. 2 Jianguomenwai Avenue,

    Chaoyang District, Beijing 100022

    The People’s Republic of China

    +86-10-6529-8300

     

     

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer ¨ Accelerated filer ¨
    Non-accelerated filer x Smaller reporting company ¨
      Emerging growth company x

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ¨

     

     

     

     

     

     

    DEREGISTRATION OF UNSOLD SECURITIES

     

    ECMOHO Limited (the “Registrant”) is filing this Post-Effective Amendment No.1 to each of the following Registration Statements on Form S-8 (collectively, the “Registration Statements”) to terminate all offerings under such Registration Statements and deregister any and all securities that remain unsold pursuant to the Registration Statements:

     

    1.Registration Statement No. 333-236027, filed with the Securities and Exchange Commission (the “SEC”) on January 23, 2020, registering the offer and sale of the Registrant’s Class A ordinary shares, par value $0.00001 per share, issuable pursuant to the 2018 Omnibus Incentive Plan.

     

    2.Registration Statement No. 333-257546, filed with the SEC on June 30, 2021, registering the offer and sale of the Registrant’s Class A ordinary shares, par value $0.00001 per share, issuable pursuant to the 2021 Omnibus Incentive Plan.

     

    On October 27, 2022, the Registrant’s American Depositary Shares and its underlying Class A ordinary shares were delisted from the Nasdaq Stock Market. Following the delisting from the Nasdaq Stock Market, the Registrant intends to deregister and terminate its reporting obligations under the Securities and Exchange Act of 1934, as amended. In connection with the delisting, the Registrant has terminated any offerings of securities pursuant to the Registration Statements. In accordance with the undertakings made by the Registrant in the Registration Statements to remove from registration by means of a post-effective amendment any of the securities that had been registered which remain unsold at the termination of the offering, the Registrant hereby removes from registration any securities of the Registrant registered but unsold under the Registration Statements as of the date hereof.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused the Post-Effective Amendments No.1 to the each of the Registration Statements to be signed on its behalf by the undersigned, thereunto duly authorized, in Shanghai, China, on December 9, 2022

     

      ECMOHO LIMITED
         
      By: /s/ Zoe Wang
      Name:  Zoe Wang
      Title: Chairwoman and Chief Executive Officer

     

    No other person is required to sign this Post-Effective Amendment in reliance upon Rule 478 under the Securities Act of 1933, as amended.

     

     

     

     

    SIGNATURE OF AUTHORIZED REPRESENTATIVE OF THE REGISTRANT

     

    Pursuant to the Securities Act of 1933, as amended, the undersigned, the duly authorized representative in the United States of ECMOHO Limited, has signed this Post-Effective Amendment No. 1 to each of the Registration Statements in New York, United States of America on December 9, 2022.

     

      Authorized U.S. Representative Cogency Global Inc.
         
      By: /s/ Colleen A. De Vries
      Name:  Colleen A. De Vries
      Title: Sr. Vice President on behalf of Cogency Global Inc.

     

    No other person is required to sign this Post-Effective Amendment in reliance upon Rule 478 under the Securities Act of 1933, as amended.

     

     

     

    Get the next $MOHO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MOHO

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $MOHO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ECMOHO Receives Approval to Transfer to Nasdaq Capital Market

    SHANGHAI, China, March 17, 2022 (GLOBE NEWSWIRE) -- ECMOHO Limited (NASDAQ:MOHO) ("ECMOHO" or the "Company"), an integrated solutions provider in the health and wellness market in China, today announced that on March 16, 2022, the Listing Qualifications department of the Nasdaq Stock Market LLC ("Nasdaq") approved the Company's request to transfer the listing of the Company's American Depositary Shares (the "ADSs") from the Nasdaq Global Market to the Nasdaq Capital Market. The transfer is expected to take effect at the opening of business on March 17, 2022. The transfer of the Company's listing to the Nasdaq Capital Market is not expected to have any impact on trading in the Company's ADS

    3/17/22 6:00:00 AM ET
    $MOHO
    Catalog/Specialty Distribution
    Consumer Discretionary

    ECMOHO Increases Digital Marketing Efforts To Drive Growth

    SHANGHAI, China, Feb. 15, 2022 (GLOBE NEWSWIRE) -- ECMOHO Limited (NASDAQ:MOHO) ("ECMOHO" or the "Company"), an integrated solutions provider in the health and wellness market in China, announced today that it will increase digital marketing efforts to achieve continuous positive marketing outcomes and profits. ECMOHO has partnered with B2C and B2B companies across industries and sectors to build brands, grow market share and increase loyalty and customer value with the right digital capabilities. ECMOHO has fully participated in Douyin to gain attention of younger audience. Through short video and live broadcasting, ECMOHO is benefiting from their strong fan base for disseminating heal

    2/14/22 9:49:36 PM ET
    $MOHO
    Catalog/Specialty Distribution
    Consumer Discretionary

    ECMOHO Limited Announces the Appointment of independent director of the Board

    SHANGHAI, China, Dec. 06, 2021 (GLOBE NEWSWIRE) -- ECMOHO Limited (NASDAQ:MOHO) ("ECMOHO" or the "Company"), an integrated solutions provider in the health and wellness market in China, today announced a change in its board of directors (the "Board"). Mr. Greg Ye tendered to the Board his resignation as an independent director of the Board, the chair and a member of the audit committee of the Board and a member of the Nominating and Corporate Governance Committee of the Board for personal reasons, effective from December 1, 2021. Mr. Greg Ye's resignation did not result from any disagreement with the Company on any matter relating to the Company's operations, policies or practice. The Bo

    12/6/21 7:30:00 AM ET
    $MOHO
    Catalog/Specialty Distribution
    Consumer Discretionary

    $MOHO
    SEC Filings

    View All

    SEC Form 15F-12B filed by ECMOHO Limited

    15F-12B - ECMOHO Ltd (0001763197) (Filer)

    12/23/22 4:00:36 PM ET
    $MOHO
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form EFFECT filed by ECMOHO Limited

    EFFECT - ECMOHO Ltd (0001763197) (Filer)

    12/15/22 12:15:21 AM ET
    $MOHO
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form POS AM filed by ECMOHO Limited

    POS AM - ECMOHO Ltd (0001763197) (Filer)

    12/9/22 4:07:18 PM ET
    $MOHO
    Catalog/Specialty Distribution
    Consumer Discretionary

    $MOHO
    Leadership Updates

    Live Leadership Updates

    View All

    ECMOHO Limited Announces the Appointment of independent director of the Board

    SHANGHAI, China, Dec. 06, 2021 (GLOBE NEWSWIRE) -- ECMOHO Limited (NASDAQ:MOHO) ("ECMOHO" or the "Company"), an integrated solutions provider in the health and wellness market in China, today announced a change in its board of directors (the "Board"). Mr. Greg Ye tendered to the Board his resignation as an independent director of the Board, the chair and a member of the audit committee of the Board and a member of the Nominating and Corporate Governance Committee of the Board for personal reasons, effective from December 1, 2021. Mr. Greg Ye's resignation did not result from any disagreement with the Company on any matter relating to the Company's operations, policies or practice. The Bo

    12/6/21 7:30:00 AM ET
    $MOHO
    Catalog/Specialty Distribution
    Consumer Discretionary

    $MOHO
    Financials

    Live finance-specific insights

    View All

    ECMOHO Limited Announces Third Quarter 2021 Unaudited Financial Results

    SHANGHAI, China, Nov. 30, 2021 (GLOBE NEWSWIRE) -- ECMOHO Limited (NASDAQ:MOHO) ("ECMOHO", "we" or the "Company"), an integrated solutions provider in the health and wellness market in China, today announced its unaudited financial results for the third quarter ended September 30, 2021. Third Quarter 2021 Operational Highlights Number of brands offered by the Company increased to 41 as of September 30, 2021 from 39 as of June 30, 2021.Number of brand partners offered by the Company increased to 30 as of September 30, 2021 from 28 as of June 30, 2021.The cumulative number of partnered healthcare experts and KOLs grew from 1,216 as of September 30, 2020 to 1,591 as of September 30, 2021.

    11/30/21 7:30:00 AM ET
    $MOHO
    Catalog/Specialty Distribution
    Consumer Discretionary

    $MOHO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by ECMOHO Limited (Amendment)

    SC 13G/A - ECMOHO Ltd (0001763197) (Subject)

    2/10/23 4:02:08 PM ET
    $MOHO
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form SC 13G/A filed by ECMOHO Limited (Amendment)

    SC 13G/A - ECMOHO Ltd (0001763197) (Subject)

    2/10/23 4:00:24 PM ET
    $MOHO
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form SC 13G/A filed

    SC 13G/A - ECMOHO Ltd (0001763197) (Subject)

    2/12/21 4:30:08 PM ET
    $MOHO
    Catalog/Specialty Distribution
    Consumer Discretionary